342 related articles for article (PubMed ID: 27306066)
1. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis.
Mentzer A; Nayee S; Omar Y; Hullah E; Taylor K; Goel R; Bye H; Shembesh T; Elliott TR; Campbell H; Patel P; Nolan A; Mansfield J; Challacombe S; Escudier M; Mathew CG; Sanderson JD; Prescott NJ
Inflamm Bowel Dis; 2016 Jul; 22(7):1552-8. PubMed ID: 27306066
[TBL] [Abstract][Full Text] [Related]
2. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Chrousos G; Anagnou NP; Roma-Giannikou E
World J Gastroenterol; 2010 Apr; 16(14):1753-8. PubMed ID: 20380008
[TBL] [Abstract][Full Text] [Related]
3. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
4. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of a Swedish cohort with orofacial granulomatosis with or without Crohn's disease.
Gale G; Östman S; Rekabdar E; Torinsson Naluai Å; Högkil K; Hasséus B; Saalman R; Jontell M
Oral Dis; 2015 Jan; 21(1):e98-104. PubMed ID: 24645728
[TBL] [Abstract][Full Text] [Related]
6. Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population.
Pranculienė G; Steponaitienė R; Skiecevičienė J; Kučinskienė R; Kiudelis G; Adamonis K; Labanauskas L; Kupčinskas L
Medicina (Kaunas); 2016; 52(6):325-330. PubMed ID: 27932194
[TBL] [Abstract][Full Text] [Related]
7. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
[TBL] [Abstract][Full Text] [Related]
8. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
[TBL] [Abstract][Full Text] [Related]
9. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population.
Baptista ML; Amarante H; Picheth G; Sdepanian VL; Peterson N; Babasukumar U; Lima HC; Kugathasan S
Inflamm Bowel Dis; 2008 May; 14(5):674-9. PubMed ID: 18200510
[TBL] [Abstract][Full Text] [Related]
10. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
[TBL] [Abstract][Full Text] [Related]
11. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.
Wang MH; Okazaki T; Kugathasan S; Cho JH; Isaacs KL; Lewis JD; Smoot DT; Valentine JF; Kader HA; Ford JG; Harris ML; Oliva-Hemker M; Cuffari C; Torbenson MS; Duerr RH; Silverberg MS; Rioux JD; Taylor KD; Nguyen GC; Wu Y; Datta LW; Hooker S; Dassopoulos T; Kittles RA; Kao LW; Brant SR
Inflamm Bowel Dis; 2012 Dec; 18(12):2277-87. PubMed ID: 22411504
[TBL] [Abstract][Full Text] [Related]
12. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
[TBL] [Abstract][Full Text] [Related]
13. NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.
Meddour Y; Chaib S; Bousseloub A; Kaddache N; Kecili L; Gamar L; Nakkemouche M; Djidjik R; Abbadi MC; Charron D; Boucekkine TE; Tamouza R
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):499-504. PubMed ID: 24679666
[TBL] [Abstract][Full Text] [Related]
14. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
[TBL] [Abstract][Full Text] [Related]
15. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children.
Amre DK; Mack DR; Morgan K; Krupoves A; Costea I; Lambrette P; Grimard G; Dong J; Feguery H; Bucionis V; Deslandres C; Levy E; Seidman EG
Inflamm Bowel Dis; 2009 Apr; 15(4):501-7. PubMed ID: 18985712
[TBL] [Abstract][Full Text] [Related]
16. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus Salivarius: A Potential Salivary Biomarker for Orofacial Granulomatosis and Crohn's Disease?
Goel RM; Prosdocimi EM; Amar A; Omar Y; Escudier MP; Sanderson JD; Wade WG; Prescott NJ
Inflamm Bowel Dis; 2019 Jul; 25(8):1367-1374. PubMed ID: 30796823
[TBL] [Abstract][Full Text] [Related]
18. Orofacial granulomatosis.
Miest R; Bruce A; Rogers RS
Clin Dermatol; 2016; 34(4):505-13. PubMed ID: 27343966
[TBL] [Abstract][Full Text] [Related]
19. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
[TBL] [Abstract][Full Text] [Related]
20. Orofacial Granulomatosis and Crohn Disease: Coincidence or Pattern? A Systematic Review.
Gavioli CFB; Florezi GP; Dabronzo MLD; Jiménez MR; Nico MMS; Lourenço SV
Dermatology; 2021; 237(4):635-640. PubMed ID: 33582676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
